The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor

被引:34
|
作者
Hu, Xiang-Qun [1 ]
Peoples, Robert W. [1 ]
机构
[1] Marquette Univ, Coll Hlth Sci, Dept Biomed Sci, Milwaukee, WI 53201 USA
关键词
D O I
10.1074/jbc.M707571200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Current receptor theory suggests that there is an equilibrium between the inactive ( R) and active (R*) conformations of ligand-gated ion channels and G protein-coupled receptors. The actions of ligands in both receptor types could be appropriately explained by this two-state model. Ligands such as agonists and antagonists affect receptor function by stabilizing one or both conformations. The 5-HT3 receptor is a member of the Cys-loop ligand-gated ion channel superfamily participating in synaptic transmission. Here we show that co-expression of the 5-HT3A and 5-HT3B receptor subunits in the human embryonic kidney (HEK) 293 cells results in a receptor that displays a low level of constitutive ( or agonist- independent) activity. Furthermore, we also demonstrate that the properties of ligands can be modified by receptor composition. Whereas the 5-hydroxytryptamine (5-HT) analog 5-methoxyindole is a partial agonist at the 5-HT3A receptor, it becomes a "protean agonist" ( functioning as an agonist and an inverse agonist at the same receptor) at the 5-HT3AB receptor ( after the Greek god Proteus, who was able to change his shape and appearance at will). In addition, the 5-HT analog 5-hydroxyindole is a positive allosteric modulator for the liganded active (AR*) conformation of the 5-HT3A and 5-HT3AB receptors and a negative allosteric modulator for the spontaneously active ( R*) conformation of the 5-HT3AB receptor, suggesting that the spontaneously active (R*) and liganded active ( AR*) conformations are differentially modulated by 5-hydroxyindole. Thus, the incorporation of the 5-HT3B subunit leads to spontaneous channel opening and altered ligand properties.
引用
收藏
页码:6826 / 6831
页数:6
相关论文
共 50 条
  • [1] Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor
    Hapfelmeier, G
    Tredt, C
    Haseneder, R
    Zieglgänsberger, W
    Eisensamer, B
    Rupprecht, R
    Rammes, G
    [J]. BIOPHYSICAL JOURNAL, 2003, 84 (03) : 1720 - 1733
  • [2] Introduction of the 5-HT3B subunit alters the functional properties of 5-HT3 receptors native to neuroblastoma cells
    Stewart, A
    Davies, PA
    Kirkness, EF
    Safa, P
    Hales, TG
    [J]. NEUROPHARMACOLOGY, 2003, 44 (02) : 214 - 223
  • [3] Characterisation of a 5-HT3B receptor subunit antiserum
    Reeves, DC
    Lummis, SCR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133
  • [4] The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine
    Baptista-Hon, Daniel T.
    Deeb, Tarek Z.
    Othman, Nidaa A.
    Sharp, Douglas
    Hales, Tim G.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (03) : 693 - 704
  • [5] The 5-HT3B subunit confers reduced sensitivity to picrotoxin when co-expressed with the 5-HT3A receptor
    Das, P
    Dillon, GH
    [J]. MOLECULAR BRAIN RESEARCH, 2003, 119 (02): : 207 - 212
  • [6] Co-expression of the 5-HT3B subunit with the 5-HT3A receptor reduces alcohol sensitivity
    Hayrapetyan, V
    Jenschke, M
    Dillon, GH
    Machu, TK
    [J]. MOLECULAR BRAIN RESEARCH, 2005, 142 (02): : 146 - 150
  • [7] THE 5-HT3 RECEPTOR-CHANNEL
    JACKSON, MB
    YAKEL, JL
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1995, 57 : 447 - 468
  • [8] Identification of 5-HT3A and 5-HT3B receptor subunits in human hippocampus
    Brady, Catherine A.
    Dover, Terri J.
    Massoura, Andrew N.
    Princivalle, Alesandra P.
    Hope, Anthony G.
    Barnes, Nicholas M.
    [J]. NEUROPHARMACOLOGY, 2007, 52 (05) : 1284 - 1290
  • [9] The 5-HT3B subunit is a major determinant of serotonin-receptor function
    Davies, PA
    Pistis, M
    Hanna, MC
    Peters, JA
    Lambert, JJ
    Hales, TG
    Kirkness, EF
    [J]. NATURE, 1999, 397 (6717) : 359 - 363
  • [10] The 5-HT3B subunit is a major determinant of serotonin-receptor function
    Paul A. Davies
    Marco Pistis
    Michael C. Hanna
    John A. Peters
    Jeremy J. Lambert
    Tim G. Hales
    Ewen F. Kirkness
    [J]. Nature, 1999, 397 : 359 - 363